Current aspects of formulation efforts and pore lifetime related to microneedle treatment of skin
- 7 March 2010
- journal article
- review article
- Published by Taylor & Francis in Expert Opinion on Drug Delivery
- Vol. 7 (5) , 617-629
Abstract
(2010). Current aspects of formulation efforts and pore lifetime related to microneedle treatment of skin. Expert Opinion on Drug Delivery: Vol. 7, No. 5, pp. 617-629.Keywords
This publication has 45 references indexed in Scilit:
- Transdermal Delivery of Naltrexol and Skin Permeability Lifetime after Microneedle Treatment in Hairless Guinea PigsJournal of Pharmaceutical Sciences, 2010
- Skin barrier disruption by acetone: observations in a hairless mouse skin modelArchives of Dermatological Research, 2009
- Optimizing microneedle arrays for transdermal drug delivery: Extension to non-square distribution of microneedlesJournal of Drug Targeting, 2009
- Micro-scale devices for transdermal drug deliveryInternational Journal of Pharmaceutics, 2008
- Transdermal drug deliveryNature Biotechnology, 2008
- Clinical administration of microneedles: skin puncture, pain and sensationBiomedical Microdevices, 2008
- Microneedles permit transdermal delivery of a skin-impermeant medication to humansProceedings of the National Academy of Sciences, 2008
- Modelling transdermal delivery of high molecular weight drugs from microneedle systemsPhilosophical Transactions of the Royal Society A: Mathematical, Physical and Engineering Sciences, 2007
- The Regulation of Permeability Barrier HomeostasisJournal of Investigative Dermatology, 2007
- Cutaneous barrier perturbation stimulates cytokine production in the epidermis of mice.Journal of Clinical Investigation, 1992